Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Resverlogix Corp T.RVX

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  RVXCF

Resverlogix Corp is a clinical stage cardiovascular company. It is engaged in developing small molecules that selectively inhibit Bromodomain and ExtraTerminal domain (BET) proteins, a new and emerging target for high risk vascular diseases.
Price: $0.78 | Change: $0.00 | %Change: 0.00%
Volume: 0 | Day High/Low: N/A/N/A | 52 Week High/Low: 1.16/0.41

Snapshot

Last Traded: July 30, 2014 11:57 Transaction Volume: 0
Open: $0.78 Previous Close: $0.78
Bid: $0.76 Ask: $0.79
Bid Size: 38,500 Ask Size: 3,000
Market Cap: $66.5m Shares Out: 85.3m
PE Ratio: 1.3 Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Opinion

Blogger says 2014 may be a good year for Canadian Zinc (T.CZN)

Stockhouse Editorial   December 24, 2013
0 stars

Stockhouse Research: Sometimes no news is good news

Another day, another bullboard war. But not much else.

Chris Parry   September 10, 2013
0 stars

Stockhouse Research: The day Niko Resources came to play

Another day, another surprising block of Stockhouse user data.

Chris Parry   September 6, 2013
0 stars

Stockhouse Research: Resverlogix (T.RVX) and Colabor (T.GCL) sparking interest

Newcomers make the list on Stockhouse Research's roundup of what's hot on Stockhouse.com today.

Chris Parry   September 3, 2013
0 stars

Latest Bullboard Posts